Stocks & ETFs Screener: 115 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Diabetes Treatments, Cancer |
666B | 75.4% | 66.1% | 35.2% | 48.3 | -31.6% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, MedicalDevices |
431B | 71.3% | 60.0% | 34.5% | 19.1 | -6.22% |
| NVO Novo Nordisk |
Pharmaceuticals
Diabetes, Obesity, Insulin |
253B | 89.9% | 58.9% | -13.2% | 14.3 | -65.3% |
| AZN AstraZeneca |
Pharmaceuticals
Cancer, Cardiovascular |
252B | 78.4% | 42.1% | 50.6% | 30.5 | -13.6% |
| ZEG AstraZeneca |
Pharmaceuticals
Cancer Drugs, Heart Drugs, Lung |
251B | 79.2% | 44.9% | 31.8% | 30.5 | -18.1% |
| NVS Novartis |
Pharmaceuticals
Pharmaceuticals, HeartFailure |
245B | 75.9% | 62.5% | 82.4% | 18.5 | -6.66% |
| MRK Merck |
Pharmaceuticals
Pharmaceuticals, Vaccines |
210B | 83.7% | 74.4% | -17.2% | 13.0 | -37.6% |
| PFE Pfizer |
Pharmaceuticals
Medicines, Vaccines, Biosimilars |
141B | 67.3% | 75.2% | -57.1% | 13.1 | -26.4% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Oncology, Immunology |
122B | 54.2% | 58.3% | 23.2% | 16.5 | -27.3% |
| SAN Sanofi |
Pharmaceuticals
Medicines, Vaccines, Oncology |
115B | 65.4% | 66.4% | -0.10% | 15.7 | -31.2% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Hematology, Immunology |
94.0B | 70.8% | 64.1% | -39.4% | 18.6 | -15.8% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
82.1B | 75.2% | 33.1% | 51.8% | 18.3 | -16.8% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
81.4B | 68.7% | 28.7% | 26.1% | 18.2 | -21.7% |
| ZTS Zoetis |
Pharmaceuticals
Animal Medicine, Vaccines |
69.3B | 87.0% | 62.8% | -34.6% | 27.0 | -33.9% |
| MRK Merck KGaA |
Pharmaceuticals
LifeScienceTools, HealthcareDrugs |
55.3B | 56.7% | 40.0% | -68.0% | 16.5 | -45.8% |
| TAK Takeda |
Pharmaceuticals
Gastroenterology,Rare,Disease,Plasm.. |
48.7B | 56.9% | 35.1% | 39.8% | 52.7 | -10.4% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
32.2B | 50.4% | 0.40% | -20.6% | - | -11.6% |
| TEVA Teva Pharma |
Pharmaceuticals
Generic Drugs, Corticosteroid |
22.5B | 55.5% | 18.5% | 43.8% | - | -7.05% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Cancer, Rare Disease |
21.1B | 58.5% | 68.0% | 18.7% | 15.8 | 14.0% |
| VTRS Viatris |
Pharmaceuticals
Generic Drugs, Biosimilars |
12.3B | 31.0% | 59.3% | -21.5% | - | -25.4% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generic Medicines, Active |
11.9B | 74.4% | 42.6% | 32.2% | 18.4 | -22.8% |
| IPN Ipsen |
Pharmaceuticals
Oncology Drugs, Neuroscience |
11.5B | 87.8% | 49.6% | 25.6% | 22.2 | -3.70% |
| SOBI Swedish Orphan |
Pharmaceuticals
Haematology, Immunology, Specialty |
9.95B | 69.9% | - | 9.65% | 21.4 | -29.4% |
| VRNA Verona Pharma |
Pharmaceuticals
Inhaled |
9.03B | 39.3% | - | 96.3% | - | 198% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
8.62B | 56.5% | - | 13.3% | 19.7 | 8.16% |
| JAZZ Jazz |
Pharmaceuticals
Oxybate,Sleep,Seizure,Cancer,HEMATO.. |
7.75B | 62.3% | - | -19.3% | - | -0.45% |
| CORT Corcept |
Pharmaceuticals
Hormonemodulator, Korlym |
7.52B | 78.7% | - | 88.5% | 63.7 | 71.4% |
| SECT-B Sectra (publ) |
Pharmaceuticals
Medical IT Systems, Cybersecurity |
6.75B | 86.6% | 46.2% | 80.0% | 107 | 3.42% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Auvelity, Sunosi, Symbravo, AXS-05 |
6.05B | 28.3% | - | 76.5% | - | 8.41% |
| CAMX Camurus |
Pharmaceuticals
Opioid Treatment, Pain Relief |
4.62B | 84.6% | - | 69.8% | 60.6 | -10.6% |
| PBH Prestige Brand |
Pharmaceuticals
Pain Powders, Diaper Rash Cream |
3.29B | 65.7% | 0.21% | 27.2% | 15.7 | -27.1% |
| PRGO Perrigo |
Pharmaceuticals
Cough Relief, Infant Formula |
3.23B | 50.9% | 65.9% | -50.1% | - | -28.1% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.20B | 86.1% | 52.6% | 13.7% | 18.8 | -23.9% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
3.00B | 62.6% | - | 55.8% | 956 | -0.83% |
| BHC Bausch Health |
Pharmaceuticals
Prescription,Surgical,Ophthalmology.. |
2.65B | 67.5% | 4.65% | -29.8% | 27.5 | -3.20% |
| HCM HUTCHMED DRC |
Pharmaceuticals
Fruquintinib, Savolitinib |
2.63B | 36.8% | - | 4.31% | 5.76 | -9.71% |
| LQDA Liquidia |
Pharmaceuticals
Inhaled,Liquid,Artery,Cancer,Pulmon.. |
2.52B | 25.6% | - | 93.3% | - | 125% |
| SUPN Supernus |
Pharmaceuticals
ADHD,Parkinsons,Epilepsy,Migraine,M.. |
2.50B | 68.0% | - | 32.5% | 38.7 | 23.6% |
| TARS Tarsus |
Pharmaceuticals
Demodex, Blepharitis, Mites, Eye |
2.47B | 27.8% | - | 63.4% | - | 30.8% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
2.45B | 59.7% | 49.6% | -85.1% | 3.50 | -54.1% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Hydrogel,Eye,Injection,Sustained-Re.. |
2.12B | 26.7% | - | 34.5% | - | 23.5% |
| HRMY Harmony |
Pharmaceuticals
Medication, Wakix, Narcolepsy |
2.12B | 87.7% | - | -24.1% | 11.9 | -28.0% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Prescription, Specialty, Generic |
2.08B | 55.1% | - | 90.4% | - | 46.2% |
| DMP Dermapharm Holding |
Pharmaceuticals
Generics, Biosimilars |
2.08B | 72.0% | 46.3% | -18.4% | 16.6 | -13.1% |
| PAHC Phibro Animal |
Pharmaceuticals
Animal Health, Medicated Feed |
1.60B | 59.6% | 36.9% | 66.5% | 33.1 | 59.8% |
| AVDL Avadel |
Pharmaceuticals
Hypnotic, Narcolepsy, Lymphatic |
1.42B | 68.3% | - | 52.2% | - | -7.24% |
| HROW Harrow Health |
Pharmaceuticals
Pharmaceutical,Imprinted,Drogs,Oint.. |
1.37B | 36.3% | - | 39.1% | - | -21.3% |
| AMPH Amphastar P |
Pharmaceuticals
Enoxaparin, Insulin, Glucagon |
1.37B | 77.8% | - | -24.3% | 11.0 | -49.3% |
| TLRY Tilray |
Pharmaceuticals
Cannabis,Beverage,Wellness,Distribu.. |
1.31B | 44.7% | - | -78.8% | - | -44.7% |
| INVA Innoviva |
Pharmaceuticals
Antibiotics, Respiratory |
1.29B | 66.5% | 2.39% | 44.6% | 35.8 | -17.0% |
| WVE Wave Life Sciences |
Pharmaceuticals
Genetic, Therapy, DNA, RNA |
1.27B | 27.7% | - | 25.4% | - | -0.09% |
| XERS Xeris |
Pharmaceuticals
Injectable, Glucagon, Diabetes |
1.27B | 34.7% | - | 78.0% | - | 120% |
| COLL Collegium |
Pharmaceuticals
Oxycodone, Hydrocodone, Opioid |
1.25B | 71.3% | - | 49.8% | 37.4 | -14.2% |
| ELVN Enliven |
Pharmaceuticals
Kinase,Inhibitors,Oncology,Pipeline |
1.24B | 25.3% | - | 4.72% | - | -24.9% |
| PCRX Pacira BioSciences |
Pharmaceuticals
Bupivacaine,Anesthetic,Injectable |
1.22B | 47.9% | - | -15.6% | - | 79.0% |
| EVT Evotec SE |
Pharmaceuticals
Drug Discovery, Small Molecules |
1.22B | 44.5% | - | -61.0% | - | -19.0% |
| CRMD CorMedix |
Pharmaceuticals
Antibiotic, Dialysis, Catheter |
1.02B | 64.5% | - | 69.9% | 17.6 | 58.4% |
| CRON Cronos |
Pharmaceuticals
Cannabis, Edibles, Oils, Vapes |
969M | 58.4% | - | -20.1% | 50.6 | -1.61% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Investigational, Therapy, Chronic |
887M | 28.1% | - | 78.0% | - | 110% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, Amx0035, Amx0114 |
877M | 36.2% | - | -12.4% | - | 293% |
| PHAT Phathom |
Pharmaceuticals
GERD,Heartburn,H.Pylori,Esophagitis |
843M | 44.3% | - | -25.7% | - | -49.0% |
| EYPT Eyepoint |
Pharmaceuticals
Therapeutics, Retinal, Durasert |
827M | 24.2% | - | 31.2% | - | 26.3% |
| TBPH Theravance |
Pharmaceuticals
YUPELRI, Ampreloxetine, TRELEGY |
699M | 74.5% | - | 44.6% | 57.8 | 48.1% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Oncology, Antiviral, Immunology |
684M | 32.1% | - | -8.87% | - | 118% |
| AQST Aquestive |
Pharmaceuticals
Film,Klaxx,Film,Sublingual,Epinephr.. |
656M | 31.1% | - | 29.7% | - | -6.77% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Wine, Beers, Spirits |
615M | 42.2% | - | -26.3% | - | -2.68% |
| TERN Terns |
Pharmaceuticals
Oncology, Obesity, Cancer |
609M | 20.7% | - | -19.1% | - | -36.1% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Pharmaceuticals |
601M | 83.9% | 87.5% | 19.7% | 7.36 | 5.14% |
| ARVN Arvinas |
Pharmaceuticals
Protein Degraders, PROTAC, Cancer |
583M | 21.2% | - | -86.4% | - | -73.5% |
| RAPP Rapport |
Pharmaceuticals
SmallMolecule, CNS, RAP-219 |
549M | 24.6% | - | -7.62% | 12.5 | 5.54% |
| MAZE Maze Therapeutics |
Pharmaceuticals
Small Molecule Inhibitors, Kidney |
525M | 49.4% | - | 76.2% | - | 33.2% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading, Payments, Tokenization |
496M | 35.8% | - | 53.3% | - | 54.7% |
| EOLS Evolus |
Pharmaceuticals
Jeuveau, Evolysse |
494M | 33.2% | - | -45.6% | - | -63.3% |
| CGC Canopy Growth |
Pharmaceuticals
Cannabis, Hemp, Extracts, Edibles |
472M | 11.3% | - | -91.0% | - | -75.6% |
| ETON Eton |
Pharmaceuticals
Rare Disease Treatments |
468M | 42.5% | - | 75.8% | - | 208% |
| SEPN Septerna, Common |
Pharmaceuticals
Oral Small Molecules, GPCR |
444M | 28.3% | - | -56.6% | - | -30.8% |
| FULC Fulcrum |
Pharmaceuticals
Small Molecules, Fetal Hemoglobin |
414M | 30.0% | - | 6.14% | - | 70.9% |
| EAPI Euroapi SAS |
Pharmaceuticals
ActivePharmaceuticalIngredients |
326M | 51.2% | - | -73.1% | - | -37.4% |
| CTNM Contineum |
Pharmaceuticals
CNS,Pain,Inflammation |
313M | 22.3% | - | -71.7% | - | -42.5% |
| ACB Aurora Cannabis |
Pharmaceuticals
Cannabis, Cannabis-Derivative |
305M | 48.1% | - | -53.7% | - | -27.6% |
| SCPH Scpharmaceuticals |
Pharmaceuticals
Furosemide, Infusor, Diuretic |
300M | 41.1% | - | 1.05% | - | -10.9% |
| OMER Omeros |
Pharmaceuticals
Drug, Omid, Pegcetacoplan |
291M | 38.0% | - | -9.29% | - | -6.79% |
| AARD Aardvark |
Pharmaceuticals
SmallMolecule Therapeutics, Oral |
284M | 16.6% | - | -49.0% | - | -44.7% |
| NMRA Neumora |
Pharmaceuticals
Depression, Schizophrenia |
282M | 21.2% | - | -86.1% | - | -88.5% |
| AVIR Atea |
Pharmaceuticals
Antiviral Therapeutics, Hepatitis |
275M | 31.1% | - | -53.2% | - | -28.1% |
| TVRD Tvardi |
Pharmaceuticals
STAT3, Inhibitor, Cancer |
242M | 39.8% | - | -16.7% | - | 193% |
| ZYBT Zhengye |
Pharmaceuticals
Veterinary Vaccines, Livestock |
235M | 41.5% | - | 81.5% | 83.2 | 70.7% |
| ACRS Aclaris |
Pharmaceuticals
Hair Loss, Skin Lesion, Immune |
223M | 21.2% | - | -38.3% | - | 40.0% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis, Vapes, Beverages |
221M | 42.1% | - | -63.4% | 165 | -24.2% |
| KG KING |
Pharmaceuticals
Cardiovascular,Neuroscience,Medicin.. |
209M | 25.7% | 14.2% | -54.5% | 2.93 | -29.9% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
Drug, Immune, Skin, Bowel |
184M | 33.7% | - | -48.1% | - | -10.1% |
| MDWD Mediwound |
Pharmaceuticals
BurnTreatment, WoundCare |
182M | 35.0% | - | 21.5% | - | -14.9% |
| BIOA BioAge Labs |
Pharmaceuticals
Oral Small Molecules, Obesity |
171M | 29.6% | - | -78.1% | - | -77.4% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Amphiphile,Lymph,Node,Cancer,Vaccin.. |
169M | 39.1% | - | 20.9% | - | 137% |
| MIST Milestone |
Pharmaceuticals
Cardiovascular, Drug Development |
149M | 20.1% | - | -41.4% | - | 12.0% |
| SCLX Scilex Holding |
Pharmaceuticals
Topical, Non-Opioid, Pain Relief |
131M | 56.6% | - | -79.3% | - | -40.5% |
| CRAD-B C-Rad (publ) |
Pharmaceuticals
Radiotherapy, Imaging, Workflow |
119M | 71.0% | - | -22.4% | 43.0 | -37.9% |
| KALA Kala |
Pharmaceuticals
Eye Disease Therapies, Corneal |
105M | 21.3% | - | -0.31% | - | 163% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Antidepressants, Bipolar |
102M | 28.4% | - | -86.2% | - | -74.9% |
| SAVA Cassava Sciences |
Pharmaceuticals
Alzheimers Drug, Pipeline |
101M | 30.9% | 0.17% | -82.2% | - | -93.7% |
| ORX Orexo |
Pharmaceuticals
Zubsolv, Abstral, Edluar |
91.6M | 44.7% | - | 27.8% | - | 41.5% |
| NTHI NeOnc Technologies |
Pharmaceuticals
Brain, Tumor, Cancer, Drugs |
90.8M | 38.0% | - | -52.7% | - | -25.3% |
| SLGL Sol Gel |
Pharmaceuticals
Topical, Dermatological, Drugs |
67.1M | 27.7% | - | -19.7% | - | 231% |
| DRRX Durect |
Pharmaceuticals
Larsucosterol, POSIMIR, PERSERIS |
59.3M | 32.1% | - | -50.0% | - | 5.01% |
| TELO Telomir |
Pharmaceuticals
Small Molecule, Metal Ion |
42.6M | 34.1% | - | -93.9% | - | -80.8% |
| QLINEA Q linea |
Pharmaceuticals
Diagnostic, Instrument, Kit |
34.2M | 38.3% | - | -89.7% | - | -93.0% |
| ITRM Iterum Therapeutics |
Pharmaceuticals
Oral Antibiotic, Anti-Infective |
30.2M | 28.1% | - | -77.5% | - | -48.4% |
| ALTHX Theranexus |
Pharmaceuticals
Drug Candidates, CNS Disorders |
26.5M | 42.8% | - | 32.0% | - | 290% |
| SNES SenesTech |
Pharmaceuticals
ContraPest, Evolve, Mouse |
25.6M | 46.2% | - | -34.8% | - | 41.8% |
| CTXR Citius |
Pharmaceuticals
Cancer, Immunotherapy, Antibiotic |
20.9M | 31.8% | - | -90.3% | - | -92.1% |
| PRPH ProPhase Labs |
Pharmaceuticals
Dietary Supplements, COVID-19 |
20.4M | 23.1% | 1.0% | -83.8% | - | -85.9% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Instaprin, Sublingual Delivery |
20.2M | 40.3% | - | -72.3% | - | -96.9% |
| NBY NovaBay |
Pharmaceuticals
Eyecare, Wound Care, Skin Care |
15.6M | 36.1% | - | -49.5% | 1.17 | 363% |
| TNFA TNF |
Pharmaceuticals
Immune System, Small Molecule |
10.9M | 25.6% | - | -98.3% | - | -97.8% |
| SNOA Sonoma |
Pharmaceuticals
Skin Care, Wound Care, Eye Care |
7.74M | 36.2% | - | -33.1% | - | 18.4% |